세계의 간질 발작 치료 시장 보고서(2025년)

Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.

The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.

The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.

The forecast of 6.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of anti-epileptic drugs and neurostimulation devices sourced from Israel and France, thereby worsening seizure control and elevating neurology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.

Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.

In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.

Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma

North America was the largest region in the epileptic seizures treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epileptic Seizures Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Treatment Practices; Emerging Drugs; Individual Therapies
• 2) By Seizure Type: Partial Seizures; Generalized Seizures; Unclassified Seizures
• 3) By Route of Administration: Oral Or Buccal; Nasal; Rectal; Parenteral
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Treatment Practices: Antiepileptic Drugs (AEDs); Surgery; Vagus Nerve Stimulation (VNS); Ketogenic Diet; Responsive Neurostimulation (RNS)
• 2) By Emerging Drugs: New Antiepileptic Medications; Cannabidiol-based Drugs; Gene Therapy-Based Treatments; Monoclonal Antibodies
• 3) By Individual Therapies: Monotherapy; Combination Therapy; Adjunctive Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Service Inc.; Sanofi S.A.; Abbott Laboratories; Novartis AG; GlaxoSmithKline plc.; Takeda Pharmaceutical Co. Ltd.; Medtronic plc; GE HealthCare Technologies Inc.; Teva Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.; UCB S.A.; Eisai Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Dragerwerk AG & Co.KGaA; H. Lundbeck A/S; Apotex Inc.; Masimo Corporation; Fisher & Paykel Healthcare Limited; Inspiration Healthcare Group Plc.; Phoenix Medical Systems (P) Ltd.; Marinus Pharmaceuticals Inc.; Alexza Pharmaceuticals Inc.; Neurelis Inc.; Veriton Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epileptic Seizures Treatment Market Characteristics

3. Epileptic Seizures Treatment Market Trends And Strategies

4. Epileptic Seizures Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Epileptic Seizures Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Epileptic Seizures Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Epileptic Seizures Treatment Market Growth Rate Analysis
• 5.4. Global Epileptic Seizures Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Epileptic Seizures Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Epileptic Seizures Treatment Total Addressable Market (TAM)

6. Epileptic Seizures Treatment Market Segmentation

• 6.1. Global Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Practices
• Emerging Drugs
• Individual Therapies
• 6.2. Global Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Partial Seizures
• Generalized Seizures
• Unclassified Seizures
• 6.3. Global Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Or Buccal
• Nasal
• Rectal
• Parenteral
• 6.4. Global Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Treatment Practices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiepileptic Drugs (AEDs)
• Surgery
• Vagus Nerve Stimulation (VNS)
• Ketogenic Diet
• Responsive Neurostimulation (RNS)
• 6.6. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Emerging Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• New Antiepileptic Medications
• Cannabidiol-based Drugs
• Gene Therapy-Based Treatments
• Monoclonal Antibodies
• 6.7. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Individual Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monotherapy
• Combination Therapy
• Adjunctive Therapy

7. Epileptic Seizures Treatment Market Regional And Country Analysis

• 7.1. Global Epileptic Seizures Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Epileptic Seizures Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epileptic Seizures Treatment Market

• 8.1. Asia-Pacific Epileptic Seizures Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epileptic Seizures Treatment Market

• 9.1. China Epileptic Seizures Treatment Market Overview
• 9.2. China Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epileptic Seizures Treatment Market

• 10.1. India Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epileptic Seizures Treatment Market

• 11.1. Japan Epileptic Seizures Treatment Market Overview
• 11.2. Japan Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epileptic Seizures Treatment Market

• 12.1. Australia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epileptic Seizures Treatment Market

• 13.1. Indonesia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epileptic Seizures Treatment Market

• 14.1. South Korea Epileptic Seizures Treatment Market Overview
• 14.2. South Korea Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epileptic Seizures Treatment Market

• 15.1. Western Europe Epileptic Seizures Treatment Market Overview
• 15.2. Western Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epileptic Seizures Treatment Market

• 16.1. UK Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epileptic Seizures Treatment Market

• 17.1. Germany Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epileptic Seizures Treatment Market

• 18.1. France Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epileptic Seizures Treatment Market

• 19.1. Italy Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epileptic Seizures Treatment Market

• 20.1. Spain Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epileptic Seizures Treatment Market

• 21.1. Eastern Europe Epileptic Seizures Treatment Market Overview
• 21.2. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epileptic Seizures Treatment Market

• 22.1. Russia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epileptic Seizures Treatment Market

• 23.1. North America Epileptic Seizures Treatment Market Overview
• 23.2. North America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epileptic Seizures Treatment Market

• 24.1. USA Epileptic Seizures Treatment Market Overview
• 24.2. USA Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epileptic Seizures Treatment Market

• 25.1. Canada Epileptic Seizures Treatment Market Overview
• 25.2. Canada Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epileptic Seizures Treatment Market

• 26.1. South America Epileptic Seizures Treatment Market Overview
• 26.2. South America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epileptic Seizures Treatment Market

• 27.1. Brazil Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epileptic Seizures Treatment Market

• 28.1. Middle East Epileptic Seizures Treatment Market Overview
• 28.2. Middle East Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epileptic Seizures Treatment Market

• 29.1. Africa Epileptic Seizures Treatment Market Overview
• 29.2. Africa Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles

• 30.1. Epileptic Seizures Treatment Market Competitive Landscape
• 30.2. Epileptic Seizures Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Epileptic Seizures Treatment Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc.
• 31.2. Takeda Pharmaceutical Co. Ltd.
• 31.3. Medtronic plc
• 31.4. GE HealthCare Technologies Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Bausch Health Companies Inc.
• 31.7. UCB S.A.
• 31.8. Eisai Co. Ltd.
• 31.9. Sumitomo Dainippon Pharma Co. Ltd.
• 31.10. Dragerwerk AG & Co.KGaA
• 31.11. H. Lundbeck A/S
• 31.12. Apotex Inc.
• 31.13. Masimo Corporation
• 31.14. Fisher & Paykel Healthcare Limited
• 31.15. Inspiration Healthcare Group Plc.

32. Global Epileptic Seizures Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market

34. Recent Developments In The Epileptic Seizures Treatment Market

35. Epileptic Seizures Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Epileptic Seizures Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Epileptic Seizures Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Epileptic Seizures Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer